$R2WA #Beximco Pharmaceuticals Ltd. GDR ... SEARL enters exclusive license agreement with Beximco Pharma for Remdesivir: In an exchange filing today, SEARL PA has announced that it has successfully entered into a licensing and marketing… https://t.co/XKd8vlP4II #equity #stocks https://t.co/pmEVtLhbD2